Bio-Rad Laboratories, Inc. (BIO.B) stock
BIO.BNYSELaboratory Analytical InstrumentsFiscal year ends December 31Also trades as BIO
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 4, 2026Score 8/3055% above fair value
$379.50+0.00 (0.00%)
Close on Oct 29, 2026Market cap $10.18BP/E 46.2Yield –
Bio-Rad Laboratories price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Bio-Rad Laboratories's price to sales ratio was 3.7× on Oct 19, 2026, against 3.5× a year earlier. Over the last 5 years it ranged from 2.5× to 7.7×, with a median of 3.8×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Oct 19, 2026 | 3.7× | +0.4 |
| 2025 | Dec 31, 2025 | 3.3× | −0.4 |
| 2024 | Dec 31, 2024 | 3.6× | +0.1 |
| 2023 | Dec 29, 2023 | 3.5× | −1.0 |
| 2022 | Dec 30, 2022 | 4.5× | −3.2 |
| 2021 | Dec 31, 2021 | 7.7× | +0.3 |
| 2020 | Dec 31, 2020 | 7.4× | +2.6 |
| 2019 | Dec 31, 2019 | 4.8× | +1.8 |
| 2018 | Dec 31, 2018 | 3.1× | −0.3 |
| 2017 | Dec 29, 2017 | 3.4× | +0.8 |
| 2016 | Dec 30, 2016 | 2.6× | +0.6 |
| 2015 | Dec 31, 2015 | 2.0× | +0.4 |
| 2014 | Dec 31, 2014 | 1.6× | −0.1 |
| 2013 | Dec 31, 2013 | 1.7× | +0.2 |
| 2012 | Dec 31, 2012 | 1.5× | +0.1 |
| 2011 | Dec 30, 2011 | 1.3× | −0.2 |
| 2010 | Dec 31, 2010 | 1.5× | +0.0 |
| 2009 | Dec 31, 2009 | 1.5× | – |